Yadanzioside C is primarily studied for its potential anti-cancer properties, particularly in inhibiting the growth of certain tumor cells. It has shown activity in inducing apoptosis in liver and lung cancer cell lines through modulation of key signaling pathways such as PI3K/AKT and MAPK. Additionally, it exhibits anti-inflammatory effects by suppressing the production of pro-inflammatory cytokines like TNF-α and IL-6, suggesting possible use in inflammation-related diseases. Research also indicates that Yadanzioside C may have neuroprotective effects, making it a candidate for further study in neurodegenerative conditions such as Alzheimer’s disease. Its application remains largely in the preclinical research phase, focusing on drug discovery and development in oncology and neurology.